FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer

Background: Resistance to endocrine treatments is a major clinical challenge in the management of estrogen receptor positive breast cancers. Although multiple mechanisms leading to endocrine resistance have been proposed, the poor outcome of this subgroup of patients demands additional studies. Meth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Pellegrino, Michele, Rizza, Pietro, Donà, Ada, Nigro, Alessandra, Ricci, Elena, Fiorillo, Marco, Perrotta, Ida, Lanzino, Marilena, Giordano, Cinzia, Bonofiglio, Daniela, Bruno, Rosalinda, Sotgia, Federica, Lisanti, Michael P., Sisci, Diego, Morelli, Catia
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6966564/
https://ncbi.nlm.nih.gov/pubmed/31769419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11121858
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados